61 /100
HIGH RISK
Score updated Jul 14, 2026

SXTP — 60 Degrees Pharmaceuticals, Inc. Dilution Risk Tracker

Track SXTP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SXTP — Get alerts when the score changes →

As of July 14, 2026, 60 Degrees Pharmaceuticals, Inc. (SXTP) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. 60 Degrees Pharmaceuticals, Inc. has a market capitalization of $3.96M, 2.66M shares outstanding, 7 institutional holders tracked. Key dilution vectors include ATM program capacity of $565.0K, 10.9K outstanding warrants, approximately 9 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
🔁 Convertible Conversion 60%
• Major convertible overhang: 37% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 40%
• 50-day avg $1.65 approaching $1 threshold
• 9 months cash with weak price
💰 Capital Raise 33%
• Under 12 months cash (9mo)
• Active ATM program with $1M remaining capacity
🔔 Track SXTP — Get forecast alerts →

💹 Market Data

Market Cap$3.96M
Shares Outstanding2.66M
Float2.44M
Cash$4.58M
Debt$3.14M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.0% shares (2025Q4 vs prior)
7 institutional holders · 44.4K shares
#1 JANE STREET GROUP, LLC 22.1K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 12.4K shares
#3 Tower Research Capital LLC (TRC) 6.7K shares
+ 4 more holders Sign up free to view →

📉 Short Interest

Short Interest112.4K
Days to Cover1.5
% of Float4.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
424B5 ATM Mar 13, 2026
424B5 ATM Mar 11, 2026
424B5 ATM Mar 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for SXTP Shareholders

60 Degrees Pharmaceuticals, Inc. (SXTP) has a DilutionScore of 61/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

SXTP has an active ATM (at-the-market) program with $0.6M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. Cash runway is a key watch item: SXTP has approximately 9 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for SXTP in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SXTP alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track SXTP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SXTP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SXTP
📊 SXTP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SXTP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.